In COVID-19 patients, the simultaneous activation of coagulation and inhibition of fibrinolysis has been demonstrated with increased levels of plasminogen activator inhibitor 1 (PAI-1) and decreased levels of d-dimer in comparison with sepsis patients [20]. The gene discussed is SERPINE1; the disease is COVID-19.